C URRENT OPINION Fibroblast growth factor signaling promotes physiological bone remodeling and stem cell self-renewal
暂无分享,去创建一个
[1] J. Rasko,et al. Nichotherapy for stem cells: there goes the neighborhood. , 2013, BioEssays : news and reviews in molecular, cellular and developmental biology.
[2] Xiaogang Wang,et al. miR-214 targets ATF4 to inhibit bone formation , 2012, Nature Medicine.
[3] L. Calvi,et al. PTH expands short-term murine hemopoietic stem cells through T cells. , 2012, Blood.
[4] S. Erzurum,et al. Endothelial Apelin-FGF Link Mediated by MicroRNAs 424 and 503 is Disrupted in Pulmonary Arterial Hypertension , 2012, Nature Medicine.
[5] R. Adams,et al. Endothelial Blood-Bone Marrow-Barrier Dynamically Regulates Balanced Stem and Progenitor Cell Trafficking and Maintenance , 2012 .
[6] Daniel G. Anderson,et al. FGF regulates TGF-β signaling and endothelial-to-mesenchymal transition via control of let-7 miRNA expression. , 2012, Cell reports.
[7] Xi C. He,et al. FGF signaling facilitates postinjury recovery of mouse hematopoietic system. , 2012, Blood.
[8] G. Enikolopov,et al. FGF-2 expands murine hematopoietic stem and progenitor cells via proliferation of stromal cells, c-Kit activation, and CXCL12 down-regulation. , 2012, Blood.
[9] A. Papadimitropoulos,et al. Fibroblast Growth Factor‐2 Maintains a Niche‐Dependent Population of Self‐Renewing Highly Potent Non‐adherent Mesenchymal Progenitors Through FGFR2c , 2012, Stem cells.
[10] L. Vecchio,et al. Interactions between bone marrow stromal microenvironment and B-chronic lymphocytic leukemia cells: any role for Notch, Wnt and Hh signaling pathways? , 2012, Cellular signalling.
[11] D. Gridley,et al. Erythroid Promoter Confines FGF2 Expression to the Marrow after Hematopoietic Stem Cell Gene Therapy and Leads to Enhanced Endosteal Bone Formation , 2012, PloS one.
[12] Lei Ding,et al. Endothelial and perivascular cells maintain haematopoietic stem cells , 2011, Nature.
[13] A. Iwama,et al. Nonmyelinating Schwann Cells Maintain Hematopoietic Stem Cell Hibernation in the Bone Marrow Niche , 2011, Cell.
[14] J. Bogousslavsky,et al. Trafermin for stroke recovery: is it time for another randomized clinical trial? , 2011, Expert opinion on biological therapy.
[15] D. Coutu,et al. Roles of FGF signaling in stem cell self-renewal, senescence and aging , 2011, Aging.
[16] Liping Xiao,et al. The impaired bone anabolic effect of PTH in the absence of endogenous FGF2 is partially due to reduced ATF4 expression. , 2011, Biochemical and biophysical research communications.
[17] D. Coutu,et al. Inhibition of cellular senescence by developmentally regulated FGF receptors in mesenchymal stem cells. , 2011, Blood.
[18] Kai-yan Liu,et al. Stromal-derived factor-1 deficiency in the bone marrow of acute myeloid leukemia , 2011, International journal of hematology.
[19] M. Vodyanik,et al. Endothelial origin of mesenchymal stem cells , 2011, Cell cycle.
[20] P. Guttorp,et al. The replication rate of human hematopoietic stem cells in vivo. , 2011, Blood.
[21] N. Horwood,et al. Inhibition of osteoclast function reduces hematopoietic stem cell numbers in vivo. , 2011, Blood.
[22] G. Lozano,et al. Mdm2 is required for survival of hematopoietic stem cells/progenitors via dampening of ROS-induced p53 activity. , 2010, Cell stem cell.
[23] Ben D. MacArthur,et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche , 2010, Nature.
[24] Ian A. White,et al. Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells. , 2010, Cell stem cell.
[25] T. Doetschman,et al. Endogenous FGF‐2 is critically important in PTH anabolic effects on bone , 2009, Journal of cellular physiology.
[26] M. Ittmann,et al. Paths of FGFR-driven tumorigenesis , 2009, Cell cycle.
[27] Angela C. Colmone,et al. Leukemic Cells Create Bone Marrow Niches That Disrupt the Behavior of Normal Hematopoietic Progenitor Cells , 2008, Science.
[28] K. Miyamoto,et al. Foxo3a is essential for maintenance of the hematopoietic stem cell pool , 2009 .
[29] S. Mohan,et al. Sca-1+ Hematopoietic Cell-based Gene Therapy with a Modified FGF-2 Increased Endosteal/Trabecular Bone Formation in Mice. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.
[30] H. Nakauchi,et al. Foxo3a is essential for maintenance of the hematopoietic stem cell pool. , 2007, Cell stem cell.
[31] J. Nardone,et al. Phosphotyrosine profiling identifies the KG-1 cell line as a model for the study of FGFR1 fusions in acute myeloid leukemia. , 2006, Blood.
[32] T. Nagasawa,et al. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. , 2006, Immunity.
[33] O. Kollet,et al. Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice. , 2006, Experimental hematology.
[34] S. Rafii,et al. Activation of FGFR1β signaling pathway promotes survival, migration and resistance to chemotherapy in acute myeloid leukemia cells , 2006, Leukemia.
[35] E. Vellenga,et al. Fibroblast Growth Factor‐1 and ‐2 Preserve Long‐Term Repopulating Ability of Hematopoietic Stem Cells in Serum‐Free Cultures , 2006, Stem cells.
[36] Ari Elson,et al. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells , 2006, Nature Medicine.
[37] Keisuke Ito,et al. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells , 2006, Nature Medicine.
[38] M. Ito,et al. Impaired bone anabolic response to parathyroid hormone in Fgf2-/- and Fgf2+/- mice. , 2006, Biochemical and biophysical research communications.
[39] T. Kipps,et al. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. , 2006, Blood.
[40] S. Rafii,et al. The bone marrow vascular niche: home of HSC differentiation and mobilization. , 2005, Physiology.
[41] Xunbin Wei,et al. In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment , 2005, Nature.
[42] P. Dell’Era,et al. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. , 2005, Cytokine & growth factor reviews.
[43] I. Kashiwakura,et al. Fibroblast growth factor and ex vivo expansion of hematopoietic progenitor cells , 2005, Leukemia & lymphoma.
[44] E. Crivellato,et al. Hematopoietic cancer and angiogenesis. , 2004, Stem cells and development.
[45] D. Ribatti,et al. Angiogenesis in acute and chronic lymphocytic leukemia. , 2004, Leukemia research.
[46] W. Berdel,et al. Overexpression of basic fibroblast growth factor and autocrine stimulation in acute myeloid leukemia. , 2003, Cancer research.
[47] D. Scadden,et al. Osteoblastic cells regulate the haematopoietic stem cell niche , 2003, Nature.
[48] Haiyang Huang,et al. Identification of the haematopoietic stem cell niche and control of the niche size , 2003, Nature.
[49] T. Doetschman,et al. Impaired Osteoclast Formation in Bone Marrow Cultures of Fgf2 Null Mice in Response to Parathyroid Hormone* , 2003, Journal of Biological Chemistry.
[50] E. Vellenga,et al. In vitro generation of long-term repopulating hematopoietic stem cells by fibroblast growth factor-1. , 2003, Developmental cell.
[51] A. Bikfalvi,et al. The role of fibroblast growth factors in vascular development. , 2002, Trends in molecular medicine.
[52] P. Dell’Era,et al. Fibroblast Growth Factors and Their Receptors in Hematopoiesis and Hematological Tumors , 2002 .
[53] E. Estey,et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. , 2000, Blood.
[54] M. Ito,et al. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. , 2000, The Journal of clinical investigation.
[55] Z. Fuks,et al. Radiation-induced apoptosis of endothelial cells in the murine central nervous system: protection by fibroblast growth factor and sphingomyelinase deficiency. , 2000, Cancer research.
[56] S. Tsang,et al. Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[57] R. Taichman,et al. The Role of Osteoblasts in the Hematopoietic Microenvironment , 1998, Stem cells.
[58] A. König,et al. Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis , 1997, Leukemia.
[59] E. Calleja,et al. Elevated intracellular level of basic fibroblast growth factor correlates with stage of chronic lymphocytic leukemia and is associated with resistance to fludarabine. , 1996, Blood.
[60] J. Rossant,et al. fgfr-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation. , 1994, Genes & development.
[61] J. Schwartz,et al. Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. , 1994, Cancer research.
[62] P. D’Amore. Modes of FGF release in vivo and in vitro , 1990, Cancer and Metastasis Reviews.
[63] P. Okunieff,et al. Fibroblast growth factor-peptide promotes bone marrow recovery after irradiation. , 2013, Advances in experimental medicine and biology.
[64] R. Kalluri,et al. Contribution of bone microenvironment to leukemogenesis and leukemia progression , 2009, Leukemia.
[65] T. J. Poole,et al. The role of FGF and VEGF in angioblast induction and migration during vascular development , 2001, Developmental dynamics : an official publication of the American Association of Anatomists.